REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 21st, 2008 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 15, 2008, by and among Optigenex Inc., a Delaware corporation with its headquarters located at 750 Lexington Avenue, 6th Floor, NY, NY 10022 (the “Company”), and each of the undersigned (together with their respective affiliates and any assignee or transferee of all of their respective rights hereunder, the “Initial Investors”).
SECURITY AGREEMENTSecurity Agreement • April 21st, 2008 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
SECURITY AGREEMENT (this “Agreement”), dated as of April 15, 2008, by and among Optigenex Inc., a Delaware corporation (“Parent” or “Company”) and the secured parties signatory hereto and their respective endorsees, transferees and assigns (collectively, the “Secured Party”).
INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • April 21st, 2008 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
INTELLECTUAL PROPERTY SECURITY AGREEMENT (this “Agreement”), dated as of April 15, 2008, by and among Optigenex Inc., a Delaware corporation (“Parent” or “Company”) and the secured parties signatory hereto and their respective endorsees, transferees and assigns (collectively, the “Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 21st, 2008 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 15, 2008, by and among Optigenex Inc., a Delaware corporation, with headquarters located at 750 Lexington Avenue, 6th Floor, New York, NY 10022 (the “Company”), and each of the purchasers set forth on the signature pages hereto (the “Buyers”).
ContractExercise Agreement • April 21st, 2008 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF APRIL 15, 2008, NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER SAID ACT OR, AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE, CUSTOMARY FOR OPINIONS OF COUNSEL IN COMPARABLE TRANSACTIONS, THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 OR REGULATION S UNDER SUCH ACT.
OPTIGENEX INC.Optigenex Inc. • April 21st, 2008 • Medicinal chemicals & botanical products
This letter sets forth the agreement of the parties hereto to amend the Applicable Percentage (as defined in the Notes) of the Notes, which are convertible into shares of the Company’s common stock, par value $.001 per share (the “Common Stock”), ever issued by the Company to the investors listed in the signature pages hereto (collectively, the “Investors”)( the “Notes”).
